MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: PMR Corporate
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

CIS Region Turns to be A Popular Location for Clinical Trials in 2012 Finds PMRCorporate - Pharmaceutical companies have discovered that CIS countries, such as Russia, Ukraine, Belarus and Georgia contain large pools of potential candidates ready to participate in clinical trials - PlaceLinkHere.com
CIS Region Turns to be A Popular Location for Clinical Trials in 2012 Finds PMRCorporate

 

NewswireToday - /newswire/ - Cracow, Malopolskie, Poland, 2012/02/13 - Pharmaceutical companies have discovered that CIS countries, such as Russia, Ukraine, Belarus and Georgia contain large pools of potential candidates ready to participate in clinical trials - PlaceLinkHere.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

However, certain circumstances have made it necessary for companies to be informed about the conditions in each country in order to proceed through the phases of a trial in an efficient and timely manner. For many companies, time is of the essence as they seek to replace products with patents nearing the expiration date.

As an aid to industry professionals, PMR Publishing has prepared Clinical trials in CIS countries 2012: Russia, Ukraine, Belarus and Georgia, Development forecasts for 2012-2014, a new report that delivers data, comparative analysis and forecasts that enable companies to navigate the obstacles and take advantage of the opportunities offered by each of these countries.

“Nowadays it is more and more difficult to find treatment-naïve patients who would be also willing to participate in clinical studies. CIS countries, due to their large populations as well as less developed healthcare systems, are currently an opportunity for pharmaceutical companies to recruit fast study participants. The markets are also quite difficult due to unclear legislation and specific business climates. Our report will help both those companies wanting to begin studies in the region, as well as those already operating on the market, to plan strategies. For this comparative analysis we have chosen the four countries with the largest number of clinical trials conducted: Russia, Ukraine, Belarus and Georgia.”

In order to locate and capitalize on new opportunities, you need direct access to the latest news, sharpest analysis, most reliable statistics and knowledgeable trends forecasting available. Read Clinical trials in CIS countries 2012: Russia, Ukraine, Belarus and Georgia, Development forecasts for 2012-2014 today, and refer to this new report from PMR on a regular basis as you monitor market expansion and contemplate new business strategies.

The document quantifies the number of clinical trials, market values, locations where trials are being conducted, the companies conducting them, and the therapeutic areas most often investigated. It examines the trends and conditions that have influenced market growth in recent years, and analyses those that have presented obstacles. The report offers profiles of the pharmaceutical corporations actively conducting trials, as well as the most prevalent CROs and sponsors in the region.

In addition to specific data on clinical trial registration time periods, the report lists specific business and legal regulations that might interfere with a trial schedule. It also supplies accurate forecasts for the trials to be completed in these four countries for the period to 2014.

While preparing Clinical trials in CIS countries 2012: Russia, Ukraine, Belarus and Georgia, Development forecasts for 2012-2014, PMR’s expert analysts have consulted their most reliable sources and created a truly unique market guide that deals with the complexities intrinsic to both the current status and future progression of this dynamic marketplace.

Please visit placelinkhere.com to learn more about the market for clinical trials in the CIS countries of Russia, Ukraine, Belarus and Georgia.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: PMR Corporate

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


CIS Region Turns to be A Popular Location for Clinical Trials in 2012 Finds PMRCorporate

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: PMRCorporate.com 
+48 12 618 90 00 marketing[.]pmrcorporate.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any PMR Corporate securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From PMR Corporate / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ipsen Data Presented During ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs
Global Pharmaceutical Contract Manufacturing Organization Market to Reach 2.14 Billion by 2024 Finds Frost & Sullivan
Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria
Global Bio-based Chemicals Market is Expected to Grow At A CAGR of 16.67% by 2027 According to Inkwood Research
Global Diabetes Drugs Market Forecast 2019-2027 Reports Inkwood Research
Dysport® Now Approved in the UK for Symptomatic Treatment of Upper Limb Spasticity in Children with Cerebral Palsy
Human Microbiome Market to Reach .08 Billion by 2023, Powered by the High Growth in Over-the-Counter Probiotics Finds Frost & Sullivan
BASF Launches Hepacor in Switzerland for the Dietary Management of Non-Alcoholic Fatty Liver Disease
FDA Grants Priority Review to Genentech’s Risdiplam for Spinal Muscular Atrophy
Ipsen Presents New Analyses Utilizing Modern Data Mining Approaches At ISPOR Europe 2019
Global Opioids Drugs Market is Projected to Grow At a CAGR of 2.52% by 2027 Reports Inkwood Research
Global Bio-Based Chemicals Market Projected to Grow At a CAGR of 16.67% by 2027 Finds Inkwood Research
The Global Animal Nutrition Market Projected to Grow At a CAGR of 5.94% by 2027 Finds Inkwood Research
FDA Approves Genentech’s Rozlytrek (entrectinib) for People With ROS1-Positive, Metastatic Non-small Cell Lung Cancer
BTG to Invest in Chinese Medical Isotope Diagnosis and Treatment Company Chengdu New Radiomedicine Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  RightITnow, Inc.





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)